The efficacy of tadalafil in improving sexual satisfication and overall satisfication in men with mild, moderate, and severe erectile dysfunction: a retrospective pooled analysis of data from randomized, placebo-controlled clinical trials

By Rosen Raymond C.   Shabsigh Ridwan   Kuritzky Louis   Wang Wei Christine   Sides Gregory D.  

Current Medical Research and Opinion, Vol. 21, Iss. 11, 2005-11 ,pp. : 1701-1709

Informa Healthcare

Access to resources Recommend Favorite

Cardiovascular safety of empagliflozin in patients with type 2 diabetes: a meta‐analysis of data from randomized placebo‐controlled trials

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 18, Iss. 10, 2016-10 ,pp. : 1034-1040

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of cardiovascular risk factors and related comorbid conditions and medical therapy reported at baseline on the treatment response to tadalafil 5 mg once‐daily in men with lower urinary tract symptoms associated with benign prostatic hyperplasia: an integrated analysis of four randomised, double‐blind, placebo‐controlled, clinical trials

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 12, 2015-12 ,pp. : 1496-1507

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Association between Erection Hardness Grading Scale and International Index of Erectile Function in Men with Erectile Dysfunction Treated with Sildenafil Citrate

By  

Urologia Internationalis, Vol. 86, Iss. 4, 2011-03 ,pp. : 434-438

Karger

Access to resources Recommend Favorite

Varenicline treatment for smoking cessation in Asian populations: a pooled analysis of placebo-controlled trials conducted in six Asian countries

By Fagerström Karl   Nakamura Masakazu   Cho Hong-Jun   Tsai Shih-Tzu   Wang Chen   Davies Simon   Ma Wendy   Lee Theodore C.   Russ Cristina  

Current Medical Research and Opinion, Vol. 26, Iss. 9, 2010-09 ,pp. : 2165-2173

Informa Healthcare

Access to resources Recommend Favorite